Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Sublingual Atropine in Healthy Volunteers
NCT04290039Phase 1Completed
- Sponsor
- Biomedical Advanced Research and Development Authority
- Start
- Jan 2020
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Myopine in organophosphate poisoning and carbamate poisoning (3 arms), sponsored by Biomedical Advanced Research and Development Authority. Primary endpoints: Area Under the Curve From Time Zero to Infinity, Area Under the Curve From Time Zero to Last Quantifiable Timepoint and 5 more. Started Jan 2020; status: completed.
02
Drugs
Myopine
03
Conditions
organophosphate poisoningcarbamate poisoning
Beyond the preview
Go deeper on NCT04290039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04290039.